Skip to main content

Doximity Announces Fiscal 2023 Second Quarter Financial Results

Q2 total revenues of $102.2 million, up 29% year-over-year

Q2 operating cash flow of $39.5 million, up 106% year-over-year

Q2 free cash flow of $37.7 million, up 109% year-over-year

Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2023 second quarter ended September 30, 2022.

“We were pleased to beat on both our top and bottom lines while delivering our first nine-figure revenue quarter,” said Jeff Tangney, co-founder and CEO at Doximity. "Our telehealth platform grew to a record 370,000 quarterly active clinicians. We will continue to invest in building tools to help physicians save time, so they can provide better care for their patients.”

Fiscal 2023 Second Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended September 30, 2021.

  • Revenue: Revenue of $102.2 million, versus $79.4 million, an increase of 29% year-over-year.
  • Net income and non-GAAP net income: Net income of $26.3 million, versus $36.1 million, representing a margin of 26%, versus 45%. Non-GAAP net income of $36.2 million, versus $41.6 million, representing a margin of 35%, versus 52%.
  • Adjusted EBITDA: Adjusted EBITDA of $46.0 million, versus $32.8 million, an increase of 40% year-over-year, representing adjusted EBITDA margins of 45%, versus 41%.
  • Net income per share and non-GAAP net income per share: Diluted net income per share was $0.12, versus $0.17, while non-GAAP diluted net income per share was $0.17, versus $0.19.
  • Operating cash flow and free cash flow: Operating cash flow of $39.5 million, versus $19.2 million, and free cash flow of $37.7 million, versus $18.1 million.

Financial Outlook

Doximity is providing guidance for its fiscal third quarter ending December 31, 2022 as follows:

  • Revenue between $110.7 million and $111.7 million.

  • Adjusted EBITDA between $47.7 million and $48.7 million.

Doximity is reiterating its guidance for its fiscal year ending March 31, 2023 as follows:

  • Revenue between $424.0 million and $432.0 million.
  • Adjusted EBITDA between $178.0 million and $186.0 million.

Stock Repurchase Program

The board of directors of Doximity authorized another program to repurchase up to $70 million of the Company’s Class A common stock. The repurchases are expected to be executed from time to time over the next 12 months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans.

Conference Call Information

Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com. The archived webcast will be available on the Company’s Investor Relations page shortly after the call.

About Doximity

Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The Company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients. For more information, visit www.doximity.com.

Forward-Looking Statements

Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act, which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations, or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors including (i) the timing and scope of anticipated stock repurchases; (ii) the impact of the COVID-19 pandemic (including the impact to our industry or on our customers’ industries, impact on general economic conditions, and government responses, restrictions, and actions related to the pandemic); (iii) our ability to retain existing members or add new members to our platform and maintain or grow their engagement with our platform; (iv) our ability to attract new customers or retain existing customers; (v) the impact of our prioritization of our members’ interests; (vi) breaches in our security measures or unauthorized access to members’ data; (vii) our ability to maintain or manage our growth, and other risks and factors that are beyond our control including, without limitation, those set forth in the section entitled “Risk Factors” in the Annual Report on Form 10-K that was filed with the SEC on May 27, 2022. Additional information will be provided in our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could cause actual results to differ materially from those contained in our forward-looking statements. The forward-looking statements made in this press release relate only to management’s beliefs and assumptions as of this date. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

DOXIMITY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

 

September 30, 2022

 

March 31, 2022

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

73,674

 

 

$

112,809

 

Marketable securities

 

676,317

 

 

 

685,304

 

Accounts receivable, net

 

79,236

 

 

 

81,073

 

Prepaid expenses and other current assets

 

15,691

 

 

 

19,439

 

Deferred contract costs, current

 

2,999

 

 

 

5,512

 

Total current assets

 

847,917

 

 

 

904,137

 

Property and equipment, net

 

11,647

 

 

 

8,488

 

Deferred income tax assets

 

50,583

 

 

 

48,558

 

Operating lease right-of-use assets

 

14,894

 

 

 

1,087

 

Intangible assets, net

 

34,232

 

 

 

7,909

 

Goodwill

 

67,940

 

 

 

18,915

 

Other assets

 

1,130

 

 

 

2,263

 

Total assets

$

1,028,343

 

 

$

991,357

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

1,106

 

 

$

463

 

Accrued expenses and other current liabilities

 

26,408

 

 

 

25,270

 

Deferred revenue, current

 

89,616

 

 

 

84,907

 

Operating lease liabilities, current

 

1,013

 

 

 

642

 

Total current liabilities

 

118,143

 

 

 

111,282

 

Deferred revenue, non-current

 

166

 

 

 

78

 

Operating lease liabilities, non-current

 

14,625

 

 

 

447

 

Contingent earn-out consideration liability, non-current

 

15,422

 

 

 

 

Other liabilities, non-current

 

1,023

 

 

 

956

 

Total liabilities

 

149,379

 

 

 

112,763

 

 

 

 

 

Stockholders' Equity

 

 

 

Preferred stock

 

 

 

 

 

Common stock

 

192

 

 

 

192

 

Additional paid-in capital

 

730,582

 

 

 

702,589

 

Accumulated other comprehensive loss

 

(21,559

)

 

 

(15,294

)

Retained earnings

 

169,749

 

 

 

191,107

 

Total stockholders' equity

 

878,964

 

 

 

878,594

 

Total liabilities and stockholders’ equity

$

1,028,343

 

 

$

991,357

 

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

 

Three Months Ended

September 30,

 

Six Months Ended

September 30,

 

2022

 

2021

 

2022

 

2021

Revenue

$

102,185

 

$

79,350

 

 

$

192,824

 

$

152,019

 

Cost of revenue(1)

 

13,210

 

 

8,951

 

 

 

26,287

 

 

16,937

 

Gross profit

 

88,975

 

 

70,399

 

 

 

166,537

 

 

135,082

 

Operating expenses(1):

 

 

 

 

 

 

 

Research and development

 

19,104

 

 

15,460

 

 

 

38,126

 

 

28,701

 

Sales and marketing

 

29,021

 

 

21,161

 

 

 

57,155

 

 

40,532

 

General and administrative

 

8,749

 

 

8,827

 

 

 

17,473

 

 

16,023

 

Total operating expenses

 

56,874

 

 

45,448

 

 

 

112,754

 

 

85,256

 

Income from operations

 

32,101

 

 

24,951

 

 

 

53,783

 

 

49,826

 

Other income, net

 

908

 

 

420

 

 

 

1,712

 

 

465

 

Income before income taxes

 

33,009

 

 

25,371

 

 

 

55,495

 

 

50,291

 

Provision for (benefit from) income taxes

 

6,710

 

 

(10,717

)

 

 

6,813

 

 

(12,119

)

Net income

$

26,299

 

$

36,088

 

 

$

48,682

 

$

62,410

 

Undistributed earnings attributable to participating securities

 

 

 

 

 

 

 

 

(18,326

)

Net income attributable to Class A and Class B common stockholders, basic and diluted

$

26,299

 

$

36,088

 

 

$

48,682

 

$

44,084

 

Net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

$

0.14

 

$

0.19

 

 

$

0.25

 

$

0.32

 

Diluted

$

0.12

 

$

0.17

 

 

$

0.23

 

$

0.27

 

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

 

193,137

 

 

186,171

 

 

 

193,042

 

 

137,154

 

Diluted

 

213,949

 

 

216,672

 

 

 

214,452

 

 

166,066

 

(1) Costs and expenses include stock-based compensation expense as follows:

 

 

Three Months Ended

September 30,

 

Six Months Ended

September 30,

 

2022

 

2021

 

2022

 

2021

Cost of revenue

$

2,392

 

$

793

 

$

4,514

 

$

1,061

Research and development

 

2,862

 

 

1,859

 

 

5,414

 

 

2,829

Sales and marketing

 

3,982

 

 

1,866

 

 

7,056

 

 

2,894

General and administrative

 

2,117

 

 

2,154

 

 

3,875

 

 

5,015

Total stock-based compensation expense

$

11,353

 

$

6,672

 

$

20,859

 

$

11,799

DOXIMITY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

 

Three Months Ended

September 30,

 

Six Months Ended

September 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

Cash flows from operating activities

 

 

 

 

 

 

 

Net income

$

26,299

 

 

$

36,088

 

 

$

48,682

 

 

$

62,410

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

Depreciation and amortization

 

2,589

 

 

 

1,158

 

 

 

4,959

 

 

 

2,311

 

Deferred income taxes

 

 

 

 

 

 

 

105

 

 

 

 

Stock-based compensation, net of amounts capitalized

 

11,353

 

 

 

6,672

 

 

 

20,859

 

 

 

11,799

 

Non-cash lease expense

 

551

 

 

 

286

 

 

 

952

 

 

 

569

 

Amortization of premium on marketable securities, net

 

1,218

 

 

 

1,264

 

 

 

2,673

 

 

 

1,561

 

Loss (gain) on sale of marketable securities

 

463

 

 

 

(72

)

 

 

500

 

 

 

(70

)

Amortization of deferred contract costs

 

2,072

 

 

 

2,452

 

 

 

4,839

 

 

 

5,656

 

Other

 

37

 

 

 

288

 

 

 

7

 

 

 

195

 

Changes in operating assets and liabilities, net of effect of acquisition:

 

 

 

 

 

 

 

Accounts receivable

 

(3,339

)

 

 

(9,978

)

 

 

2,194

 

 

 

(5,556

)

Prepaid expenses and other assets

 

2,405

 

 

 

(14,867

)

 

 

3,651

 

 

 

(17,728

)

Deferred contract costs

 

(1,476

)

 

 

(1,483

)

 

 

(2,342

)

 

 

(2,975

)

Accounts payable, accrued expenses and other liabilities

 

1,635

 

 

 

1,478

 

 

 

(4,474

)

 

 

(780

)

Deferred revenue

 

(4,280

)

 

 

(3,967

)

 

 

1,872

 

 

 

(4,427

)

Operating lease liabilities

 

(13

)

 

 

(167

)

 

 

(211

)

 

 

(638

)

Net cash provided by operating activities

 

39,514

 

 

 

19,152

 

 

 

84,266

 

 

 

52,327

 

Cash flows from investing activities

 

 

 

 

 

 

 

Cash paid for acquisition

 

 

 

 

 

 

 

(53,500

)

 

 

 

Purchases of property and equipment

 

(766

)

 

 

(200

)

 

 

(1,476

)

 

 

(241

)

Internal-use software development costs

 

(1,051

)

 

 

(900

)

 

 

(2,466

)

 

 

(1,671

)

Purchases of marketable securities

 

(82,307

)

 

 

(1,088,768

)

 

 

(91,177

)

 

 

(1,156,143

)

Maturities of marketable securities

 

16,167

 

 

 

24,787

 

 

 

24,438

 

 

 

35,551

 

Sales of marketable securities

 

49,434

 

 

 

531,076

 

 

 

64,158

 

 

 

531,076

 

Net cash used in investing activities

 

(18,523

)

 

 

(534,005

)

 

 

(60,023

)

 

 

(591,428

)

Cash flows from financing activities

 

 

 

 

 

 

 

Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions

 

 

 

 

 

 

 

 

 

 

553,905

 

Proceeds from issuance of common stock upon exercise of stock options and common stock warrants

 

2,570

 

 

 

2,323

 

 

 

5,584

 

 

 

5,060

 

Proceeds from issuance of common stock in connection with the employee stock purchase plan

 

2,341

 

 

 

 

 

 

2,341

 

 

 

 

Taxes paid related to net share settlement of equity awards

 

(1,152

)

 

 

(56

)

 

 

(1,261

)

 

 

(56

)

Repurchase of common stock

 

(61,168

)

 

 

 

 

 

(70,042

)

 

 

(2,698

)

Payments of deferred offering costs

 

 

 

 

(2,214

)

 

 

 

 

 

(3,982

)

Net cash provided by (used in) financing activities

 

(57,409

)

 

 

53

 

 

 

(63,378

)

 

 

552,229

 

Net increase (decrease) in cash and cash equivalents

 

(36,418

)

 

 

(514,800

)

 

 

(39,135

)

 

 

13,128

 

Cash and cash equivalents, beginning of period

 

110,092

 

 

 

594,321

 

 

 

112,809

 

 

 

66,393

 

Cash and cash equivalents, end of period

$

73,674

 

 

$

79,521

 

 

$

73,674

 

 

$

79,521

 

Non-GAAP Financial Measures

To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), the Company uses the following non-GAAP measures of financial performance:

  • Non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income margin, and non-GAAP basic and diluted net income per common share: We exclude the effect of stock-based compensation expense, amortization of acquired intangible assets, change in fair value of contingent earn-out consideration liability, and expenses associated with acquisitions from non-GAAP gross profit, non-GAAP gross margin and non-GAAP operating income. Non-GAAP net income and non-GAAP net income margin are further adjusted for estimated income tax on such adjustments. We calculate income taxes on the adjustments by applying an estimated annual effective tax rate to the adjustments. Non-GAAP basic and diluted net income per common share is non-GAAP net income attributable to common stockholders divided by the weighted average number of shares. For both basic and diluted non-GAAP net income per share, the weighted average shares we use in computing non-GAAP net income per share is equal to our GAAP weighted average shares. Non-GAAP gross margin represents non-GAAP gross profit as a percentage of revenue and non-GAAP net income margin represents non-GAAP net income as a percentage of revenue.
  • Adjusted EBITDA and adjusted EBITDA margin: We define adjusted EBITDA as net income before interest, income taxes, depreciation, and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, change in fair value of contingent earn-out consideration liability, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.
  • Free cash flow: We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs.

We use these non-GAAP financial measures internally for financial and operational decision-making purposes and as a means to evaluate period-to-period comparisons. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with our condensed consolidated financial statements prepared in accordance with GAAP. Our presentation of non-GAAP financial measures may not be comparable to similar measures used by other companies. We encourage investors to carefully consider our results under GAAP, as well as our supplemental non-GAAP information and the reconciliation between these presentations, to more fully understand our business. Please see the tables included at the end of this release for the reconciliation of GAAP to non-GAAP results.

Key Business Metrics1

  • Net revenue retention rate: Net revenue retention rate is calculated by taking the trailing 12-month (“TTM”) subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods, and reflects customer renewals, expansion, contraction, and churn. Our net revenue retention rate is directly tied to our revenue growth rate and thus fluctuates as that growth rate fluctuates.
  • Customers with trailing 12-month subscription revenue greater than $100,000: The number of customers with TTM subscription revenue greater than $100,000 is a key indicator of the scale of our business, and is calculated by counting the number of customers that contributed more than $100,000 in subscription revenue in the TTM period. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity.

1 The metric excludes the impact of the AMiON acquisition, which closed on April 1, 2022, including customers of, and subscription revenue generated from, the AMiON on-call scheduling and messaging application and was immaterial to the periods presented.

Reconciliation of GAAP to Non-GAAP Financial Measures

The following tables reconcile the specific items excluded from GAAP metrics in the calculation of non-GAAP metrics for the periods shown below:

 

Three Months Ended

September 30,

 

Six Months Ended

September 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

(unaudited)

 

(in thousands, except percentages)

Net income

$

26,299

 

 

$

36,088

 

 

$

48,682

 

 

$

62,410

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

30

 

 

 

 

Stock-based compensation

 

11,353

 

 

 

6,672

 

 

 

20,859

 

 

 

11,799

 

Depreciation and amortization

 

2,589

 

 

 

1,158

 

 

 

4,959

 

 

 

2,311

 

Provision for (benefit from) income taxes

 

6,710

 

 

 

(10,717

)

 

 

6,813

 

 

 

(12,119

)

Change in fair value of contingent earn-out consideration liability

 

(40

)

 

 

 

 

 

(94

)

 

 

 

Other income, net

 

(908

)

 

 

(420

)

 

 

(1,712

)

 

 

(465

)

Adjusted EBITDA

$

46,003

 

 

$

32,781

 

 

$

79,537

 

 

$

63,936

 

 

 

 

 

 

 

 

 

Revenue

$

102,185

 

 

$

79,350

 

 

$

192,824

 

 

$

152,019

 

Net income margin

 

26

%

 

 

45

%

 

 

25

%

 

 

41

%

Adjusted EBITDA margin

 

45

%

 

 

41

%

 

 

41

%

 

 

42

%

 

Three Months Ended

September 30,

 

Six Months Ended

September 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

(unaudited)

 

(in thousands)

Net cash provided by operating activities

$

39,514

 

 

$

19,152

 

 

$

84,266

 

 

$

52,327

 

Purchases of property and equipment

 

(766

)

 

 

(200

)

 

 

(1,476

)

 

 

(241

)

Internal-use software development costs

 

(1,051

)

 

 

(900

)

 

 

(2,466

)

 

 

(1,671

)

Free cash flow

$

37,697

 

 

$

18,052

 

 

$

80,324

 

 

$

50,415

 

Other cash flow components:

 

 

 

 

 

 

 

Net cash used in investing activities

$

(18,523

)

 

$

(534,005

)

 

$

(60,023

)

 

$

(591,428

)

Net cash provided by (used in) financing activities

$

(57,409

)

 

$

53

 

 

$

(63,378

)

 

$

552,229

 

 

Three Months Ended

September 30,

 

Six Months Ended

September 30,

 

 

2022

 

 

 

2021

 

 

 

2022

 

 

 

2021

 

 

(unaudited)

 

(in thousands, except per share data and percentages)

GAAP cost of revenue

$

13,210

 

 

$

8,951

 

 

$

26,287

 

 

$

16,937

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(2,392

)

 

 

(793

)

 

 

(4,514

)

 

 

(1,061

)

Amortization of acquired intangibles

 

(137

)

 

 

 

 

 

(273

)

 

 

 

Non-GAAP cost of revenue

$

10,681

 

 

$

8,158

 

 

$

21,500

 

 

$

15,876

 

 

 

 

 

 

 

 

 

GAAP gross profit

$

88,975

 

 

$

70,399

 

 

$

166,537

 

 

$

135,082

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

2,392

 

 

 

793

 

 

 

4,514

 

 

 

1,061

 

Amortization of acquired intangibles

 

137

 

 

 

 

 

 

273

 

 

 

 

Non-GAAP gross profit

$

91,504

 

 

$

71,192

 

 

$

171,324

 

 

$

136,143

 

 

 

 

 

 

 

 

 

GAAP gross margin

 

87

%

 

 

89

%

 

 

86

%

 

 

89

%

Non-GAAP gross margin

 

90

%

 

 

90

%

 

 

89

%

 

 

90

%

 

 

 

 

 

 

 

 

GAAP research and development expense

$

19,104

 

 

$

15,460

 

 

$

38,126

 

 

$

28,701

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(2,862

)

 

 

(1,859

)

 

 

(5,414

)

 

 

(2,829

)

Non-GAAP research and development expense

$

16,242

 

 

$

13,601

 

 

$

32,712

 

 

$

25,872

 

 

 

 

 

 

 

 

 

GAAP sales and marketing expense

$

29,021

 

 

$

21,161

 

 

$

57,155

 

 

$

40,532

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Stock-based compensation

 

(3,982

)

 

 

(1,866

)

 

 

(7,056

)

 

 

(2,894

)

Amortization of acquired intangibles

 

(1,061

)

 

 

(265

)

 

 

(2,124

)

 

 

(530

)

Change in fair value of contingent earn-out consideration liability

 

40

 

 

 

 

 

 

94

 

 

 

 

Non-GAAP sales and marketing expense

$

24,018

 

 

$

19,030

 

 

$

48,069

 

 

$

37,108

 

 

 

 

 

 

 

 

 

GAAP general and administrative expense

$

8,749

 

 

$

8,827

 

 

$

17,473

 

 

$

16,023

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

(30

)

 

 

 

Stock-based compensation

 

(2,117

)

 

 

(2,154

)

 

 

(3,875

)

 

 

(5,015

)

Non-GAAP general and administrative expense

$

6,632

 

 

$

6,673

 

 

$

13,568

 

 

$

11,008

 

 

 

 

 

 

 

 

 

GAAP operating expense

$

56,874

 

 

$

45,448

 

 

$

112,754

 

 

$

85,256

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

(30

)

 

 

 

Stock-based compensation

 

(8,961

)

 

 

(5,879

)

 

 

(16,345

)

 

 

(10,738

)

Amortization of acquired intangibles

 

(1,061

)

 

 

(265

)

 

 

(2,124

)

 

 

(530

)

Change in fair value of contingent earn-out consideration liability

 

40

 

 

 

 

 

 

94

 

 

 

 

Non-GAAP operating expense

$

46,892

 

 

$

39,304

 

 

$

94,349

 

 

$

73,988

 

 

GAAP operating income

$

32,101

 

 

$

24,951

 

 

$

53,783

 

 

$

49,826

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

30

 

 

 

 

Stock-based compensation

 

11,353

 

 

 

6,672

 

 

 

20,859

 

 

 

11,799

 

Amortization of acquired intangibles

 

1,198

 

 

 

265

 

 

 

2,397

 

 

 

530

 

Change in fair value of contingent earn-out consideration liability

 

(40

)

 

 

 

 

 

(94

)

 

 

 

Non-GAAP operating income

$

44,612

 

 

$

31,888

 

 

$

76,975

 

 

$

62,155

 

 

 

 

 

 

 

 

 

GAAP net income

$

26,299

 

 

$

36,088

 

 

$

48,682

 

 

$

62,410

 

Adjusted to exclude the following:

 

 

 

 

 

 

 

Acquisition and other related expenses

 

 

 

 

 

 

 

30

 

 

 

 

Stock-based compensation

 

11,353

 

 

 

6,672

 

 

 

20,859

 

 

 

11,799

 

Amortization of acquired intangibles

 

1,198

 

 

 

265

 

 

 

2,397

 

 

 

530

 

Change in fair value of contingent earn-out consideration liability

 

(40

)

 

 

 

 

 

(94

)

 

 

 

Income tax effect of non-GAAP adjustments (1)

 

(2,627

)

 

 

(1,457

)

 

 

(4,870

)

 

 

(2,589

)

Non-GAAP net income

$

36,183

 

 

$

41,568

 

 

$

67,004

 

 

$

72,150

 

Non-GAAP net income margin

 

35

%

 

 

52

%

 

 

35

%

 

 

47

%

 

 

 

 

 

 

 

 

GAAP undistributed earnings attributable to participating securities

$

 

 

$

 

 

$

 

 

$

(18,326

)

Impact on undistributed earnings attributable to participating securities due to non-GAAP adjustments

 

 

 

 

 

 

 

 

 

 

(2,055

)

Non-GAAP undistributed earnings attributable to participating securities

$

 

 

$

 

 

$

 

 

$

(20,381

)

 

 

 

 

 

 

 

 

Non-GAAP net income

$

36,183

 

 

$

41,568

 

 

$

67,004

 

 

$

72,150

 

Non-GAAP undistributed earnings attributable to participating securities

 

 

 

 

 

 

 

 

 

 

(20,381

)

Non-GAAP net income attributable to Class A and Class B stockholders, basic and diluted

$

36,183

 

 

$

41,568

 

 

$

67,004

 

 

$

51,769

 

 

 

 

 

 

 

 

 

Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:

 

 

 

 

 

 

 

Basic

 

193,137

 

 

 

186,171

 

 

 

193,042

 

 

 

137,154

 

Diluted

 

213,949

 

 

 

216,672

 

 

 

214,452

 

 

 

166,066

 

 

 

 

 

 

 

 

 

Non-GAAP net income per share attributable to Class A and Class B stockholders:

 

 

 

 

 

 

 

Basic

$

0.19

 

 

$

0.22

 

 

$

0.35

 

 

$

0.38

 

Diluted

$

0.17

 

 

$

0.19

 

 

$

0.31

 

 

$

0.31

 

(1)

For the three and six months ended September 30, 2022 and 2021, management used an estimated annual effective non-GAAP tax rate of 21.0%.

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.